Veradermics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Connecticut, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
470 James St Ste 14, New Haven, Connecti...Phone Number
(228) 372-3376Website
www.veradermics.comRevenue
-Stock Symbol
MANEIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About Veradermics
Veradermics is a clinical-stage biopharmaceutical company developing innovative, non-hormonal treatments for dermatologic and aesthetic conditions, with a lead program focused on oral therapies for hair regrowth.Explore more
Veradermics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Veradermics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Veradermics had a recent Job posting/layoffs
Check if Veradermics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Veradermics has new funding data
Check out if Veradermics is spiking on competitors!
Earning: See what the market has to say on Veradermics recently announced quarterly report
Veradermics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Veradermics launches new products
Congratulate Masked Content for being promoted to Masked Content at Veradermics
Recommended Actions
Reach out to Masked Content who joined Veradermics as Masked Content
Find more new buyers
Compare Similar Companies to Veradermics
Compare insights from companies similar to Veradermics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Veradermics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Veradermics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Veradermics.
Veradermics financials insights
Gather financial insights about Veradermics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series B
$75M
2025
Series C
$150M
Private Equity
$135M
2026
IPO
$256.3M
Veradermics Tech Stack
A closer look at the technologies used by Veradermics
Most Recent Scoops
Open Position
Open Position
Open Position
Project
conducted Study 302, a registration-directed Phase II-III trial of approximately 500 male subjects aged 18 to 65 across 44 US sites, in which participants were randomized to receive VDPHL01 once daily, twice daily, or placebo, with a primary endpoint period of 6 months followed by an ongoing extension study.
Medical Research, Clinical Operations
Project
Clinical Operations
Veradermics News & Media
Is Veradermics, Incorporated (MANE) A Good Stock To Buy Now?
Is MANE a good stock to buy? We came across a bullish thesis on Veradermics, Incorporated on TradersPro’s Substack. In this article, we will summarize the bulls’ thesis on MANE. Veradermics, Incorporated’s share was trading at $90.95 as of June 16th. Veradermics, Incorporated (MANE) is a clinical-stage biopharmaceutical company focused on developing innovative dermatology therapies targeting common […]Veradermics, Incorporated (MANE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Prepared Remarks Transcript
Veradermics, Incorporated (MANE) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 2:00 PM EDTCompany ParticipantsReid Waldman - CEO...Here is Why Veradermics (MANE) is One of the Best Performing NYSE Stocks So Far in 2026
Veradermics Inc. (NYSE:MANE) is one of the best performing NYSE stocks so far in 2026. On May 12, Veradermics reported a net loss of $27.2 million for Q1 2026, compared to a net loss of $12.4 million in the prior-year period. Driven by the late-stage clinical progress of its main pipeline asset, VDPHL01, R&D expenses […]This Fund Has a $75 Million Bet on a Hair Loss Biotech Stock Up More Than 500% Post-IPO
Veradermics develops novel dermatology treatments, targeting both adult and pediatric markets with a research-driven approach.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Veradermics
Sign Up For FreeTo access detailed company insights
Veradermics is a clinical-stage biopharmaceutical company developing innovative, non-hormonal treatments for dermatologic and aesthetic conditions, with a lead program focused on oral therapies for hair regrowth.... Read More
